Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05727878
Status:
RECRUITING
Last Update Posted:
2023-11-07
First Post:
2023-02-06
Brief Title:
Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED
Sponsor:
Combangio Inc
Organization:
Kala Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-06
First Submit QC Date:
February 6 2023
Study First Post Date:
2023-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-04
Last Update Post Date:
2023-11-07
Last Update Post Date Type:
ACTUAL